Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

By M. Stahl, M. Walz, M. Stuschke, N. Lehmann, H. Meyer, J. Riera-Knorrenschild, P. Langer, R. Engenhart-Cabillic, M. Bitzer, A. Königsrainer and 2 more. Journal of Clinical Oncology, 2009

948 citations recorded by the source corpus.

Subfields: Gastroenterology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/ad267867ea7adea8175ad335cd3a8f06561e305b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. H. Kato
2. H. Igaki
3. Florian Lordick
4. Kenichi Nakamura
5. M. Shinoda
6. S. Ozawa
7. N. Ando
8. H. Shimizu

Citations in the corpus

• Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013, result): “The preference for chemoradiotherapy is also supported by the results of a phase III study which compared chemoradiotherapy to chemotherapy before surgery [23].”
• A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) (2011, background): “chemotherapy or preoperative chemoradiotherapy, still needs to be clarified, and now we are planning the next clinical trial to resolve that question.(16)”